Publication of Unaudited Standalone and Consolidated Financial Results for the quarter ended 30-06-2026
RESULTS
▲ Positive Development
MEDIUM RISK
📅 Filed on BSE: 29 Jul 2026, 02:59 PM IST · BSE ID: e2638dc1-caa4-465e-be21-f7e7a32067c7
View Original BSE Filing (PDF)
💡
In Simple Terms
Indoco Remedies published its financial results for the first quarter, showing standalone net profit of Rs. 8,232 Lakhs.
🤖 AI Summary
- Indoco Remedies reported unaudited Standalone Net Profit of Rs. 8,232 Lakhs for the quarter ended 30th June 2026.
- Unaudited Consolidated Net Profit stood at Rs. 6,544 Lakhs for the quarter ended 30th June 2026.
- Standalone Total Income from Operations was Rs. 40,897 Lakhs for the quarter ended 30th June 2026.
- Consolidated Total Income from Operations reached Rs. 46,750 Lakhs for the quarter ended 30th June 2026.
- Basic Earnings per share (standalone) was Rs. 8.92, and Rs. 7.09 (consolidated) for the quarter.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Standalone Total Income from Operations (Q1 FY27)
40,897 Lakhs
3.71%
Standalone Net Profit (after tax) (Q1 FY27)
8,232 Lakhs
Not comparable — limited prior period data.
Consolidated Total Income from Operations (Q1 FY27)
46,750 Lakhs
6.33%
Consolidated Net Profit (after tax) (Q1 FY27)
6,544 Lakhs
Not comparable — limited prior period data.
Standalone Basic EPS (Q1 FY27)
8.92
Not comparable — limited prior period data.
Consolidated Basic EPS (Q1 FY27)
7.09
Not comparable — limited prior period data.
🏢 How This Affects the Company
The company recorded a Standalone Net Profit of Rs. 8,232 Lakhs for Q1 FY27, compared to a net loss of Rs. 2,807 Lakhs in the same prior period. Consolidated Net Profit also shifted to Rs. 6,544 Lakhs from a net loss of Rs. 3,635 Lakhs.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this financial results publication.
👤
Who Is Affected
All shareholders are affected by the company's financial performance as reported in the unaudited standalone and consolidated results, which show basic EPS of Rs. 8.92 (standalone) and Rs. 7.09 (consolidated).
🔍
Management Signal
The publication of results reflects management's adherence to SEBI Regulation 30 and 47 for disclosing financial performance.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 results — monitor trend in Total Income from Operations.
Subsequent quarterly filings — observe consistency in profit generation.
Updates on exceptional/extraordinary items influencing profit figures.
MEDIUM RISK
While profit shows a strong recovery, the sequential decline in total income from operations presents a moderate risk.
💡 Investor Takeaway
Indoco Remedies reported Standalone Net Profit of Rs. 8,232 Lakhs for Q1 FY27, compared to a net loss of Rs. 2,807 Lakhs in Q1 FY26. Consolidated Net Profit was Rs. 6,544 Lakhs for Q1 FY27 versus a net loss of Rs. 3,635 Lakhs in Q1 FY26.
⚖️ Strengths & Concerns
✅ Positives
- Standalone Net Profit for Q1 FY27 was Rs. 8,232 Lakhs, a significant increase from a net loss of Rs. 2,807 Lakhs in Q1 FY26.
- Consolidated Net Profit for Q1 FY27 was Rs. 6,544 Lakhs, improving from a net loss of Rs. 3,635 Lakhs in Q1 FY26.
⚠️ Concerns
- Standalone Total Income from Operations decreased to Rs. 40,897 Lakhs in Q1 FY27 from Rs. 44,913 Lakhs in Q4 FY26.
- Consolidated Total Income from Operations decreased to Rs. 46,750 Lakhs in Q1 FY27 from Rs. 47,561 Lakhs in Q4 FY26.
📅 Company Track Record
Indoco Remedies previously reported a Q1 FY27 Standalone Net Profit of Rs. 8,232 Lakhs on July 28, 2026. Prior to this, Q4 FY26 Standalone Net Profit was Rs. 2,732 Lakhs, with a recommended dividend of Rs. 0.20.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Indoco Remedies' standalone net profit for Q1 FY27?
Indoco Remedies reported an unaudited standalone net profit after tax of Rs. 8,232 Lakhs for the quarter ended 30th June 2026.
What was Indoco Remedies' consolidated net profit for Q1 FY27?
The consolidated net profit after tax (attributable to shareholders) for Indoco Remedies was Rs. 6,499 Lakhs for the quarter ended 30th June 2026.
What was the standalone total income from operations for Indoco Remedies in Q1 FY27?
Indoco Remedies' standalone total income from operations for the quarter ended 30th June 2026 was Rs. 40,897 Lakhs.
What was Indoco Remedies' basic earnings per share (standalone) in Q1 FY27?
The basic earnings per share for Indoco Remedies (standalone) for the quarter ended 30th June 2026 was Rs. 8.92.
How does Indoco Remedies' Q1 FY27 standalone net profit compare to Q1 FY26?
Indoco Remedies' standalone net profit of Rs. 8,232 Lakhs in Q1 FY27 represents a significant improvement from a standalone net loss of Rs. 2,807 Lakhs in Q1 FY26.
Questions based on this BSE filing only. For information purposes.